Last updated at 23 hours ago
Director
DIN: 09604676
Prakash Tiwari is currently associated with 2 companies in various capacities such as Individual Promoter, Managing Director and Director. They serve as a Director at PSURYAA PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09604676.Prakash Tiwari is currently involved in 3 different roles. Their most recent position is with VESPER HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Prakash Tiwari was appointed to as a director was PSURYAA PHARMA PRIVATE LIMITED. Prakash Tiwari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Prakash Tiwari is currently associated with 2 companies in various capacities such as Individual Promoter, Managing Director and Director. They serve as a Director at PSURYAA PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09604676.Prakash Tiwari is currently involved in 3 different roles. Their most recent position is with VESPER HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Prakash Tiwari was appointed to as a director was PSURYAA PHARMA PRIVATE LIMITED. Prakash Tiwari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
7 Months 4 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
PSURYAA PHARMA PRIVATE LIMITED | Individual Promoter | 12-May-2022 |
PSURYAA PHARMA PRIVATE LIMITED | Managing Director | 12-May-2022 |
VESPER HEALTHCARE PRIVATE LIMITED | Individual Promoter | 13-Jul-2022 |
VESPER HEALTHCARE PRIVATE LIMITED | Director | 13-Jul-2022 |